Cargando…

Alterations in Beta Cell Identity in Type 1 and Type 2 Diabetes

PURPOSE OF REVIEW: To discuss the current understanding of “β cell identity” and factors underlying altered identity of pancreatic β cells in diabetes, especially in humans. RECENT FINDINGS: Altered identity of β cells due to dedifferentiation and/or transdifferentiation has been proposed as a mecha...

Descripción completa

Detalles Bibliográficos
Autores principales: Moin, Abu Saleh Md, Butler, Alexandra E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689286/
https://www.ncbi.nlm.nih.gov/pubmed/31401713
http://dx.doi.org/10.1007/s11892-019-1194-6
_version_ 1783443014966837248
author Moin, Abu Saleh Md
Butler, Alexandra E.
author_facet Moin, Abu Saleh Md
Butler, Alexandra E.
author_sort Moin, Abu Saleh Md
collection PubMed
description PURPOSE OF REVIEW: To discuss the current understanding of “β cell identity” and factors underlying altered identity of pancreatic β cells in diabetes, especially in humans. RECENT FINDINGS: Altered identity of β cells due to dedifferentiation and/or transdifferentiation has been proposed as a mechanism of loss of β cells in diabetes. In dedifferentiation, β cells do not undergo apoptosis; rather, they lose their identity and function. Dedifferentiation is well characterized by the decrease in expression of key β cell markers such as genes encoding major transcription factors, e.g., MafA, NeuroD1, Nkx6.1, and Foxo1, and an increase in atypical or “disallowed” genes for β cells such as lactate dehydrogenase, monocarboxylate transporter MCT1, or progenitor cell genes (Neurog3, Pax4, or Sox9). Moreover, altered identity of mature β cells in diabetes also involves transdifferentiation of β cells into other islet hormone producing cells. For example, overexpression of α cell specific transcription factor Arx or ablation of Pdx1 resulted in an increase of α cell numbers and a decrease in β cell numbers in rodents. The frequency of α-β double-positive cells was also prominent in human subjects with T2D. These altered identities of β cells likely serve as a compensatory response to enhance function/expand cell numbers and may also camouflage/protect cells from ongoing stress. However, it is equally likely that this may be a reflection of new cell formation as a frank regenerative response to ongoing tissue injury. Physiologically, all these responses are complementary. SUMMARY: In diabetes, (1) endocrine identity recapitulates the less mature/less-differentiated fetal/neonatal cell type, possibly representing an adaptive mechanism; (2) residual β cells may be altered in their subtype proportions or other molecular features; (3) in humans, “altered identity” is a preferable term to dedifferentiation as their cellular fate (differentiated cells losing identity or progenitors becoming more differentiated) is unclear as yet.
format Online
Article
Text
id pubmed-6689286
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-66892862019-08-23 Alterations in Beta Cell Identity in Type 1 and Type 2 Diabetes Moin, Abu Saleh Md Butler, Alexandra E. Curr Diab Rep Pathogenesis of Type 1 Diabetes (A Pugliese and SJ Richardson, Section Editors) PURPOSE OF REVIEW: To discuss the current understanding of “β cell identity” and factors underlying altered identity of pancreatic β cells in diabetes, especially in humans. RECENT FINDINGS: Altered identity of β cells due to dedifferentiation and/or transdifferentiation has been proposed as a mechanism of loss of β cells in diabetes. In dedifferentiation, β cells do not undergo apoptosis; rather, they lose their identity and function. Dedifferentiation is well characterized by the decrease in expression of key β cell markers such as genes encoding major transcription factors, e.g., MafA, NeuroD1, Nkx6.1, and Foxo1, and an increase in atypical or “disallowed” genes for β cells such as lactate dehydrogenase, monocarboxylate transporter MCT1, or progenitor cell genes (Neurog3, Pax4, or Sox9). Moreover, altered identity of mature β cells in diabetes also involves transdifferentiation of β cells into other islet hormone producing cells. For example, overexpression of α cell specific transcription factor Arx or ablation of Pdx1 resulted in an increase of α cell numbers and a decrease in β cell numbers in rodents. The frequency of α-β double-positive cells was also prominent in human subjects with T2D. These altered identities of β cells likely serve as a compensatory response to enhance function/expand cell numbers and may also camouflage/protect cells from ongoing stress. However, it is equally likely that this may be a reflection of new cell formation as a frank regenerative response to ongoing tissue injury. Physiologically, all these responses are complementary. SUMMARY: In diabetes, (1) endocrine identity recapitulates the less mature/less-differentiated fetal/neonatal cell type, possibly representing an adaptive mechanism; (2) residual β cells may be altered in their subtype proportions or other molecular features; (3) in humans, “altered identity” is a preferable term to dedifferentiation as their cellular fate (differentiated cells losing identity or progenitors becoming more differentiated) is unclear as yet. Springer US 2019-08-10 2019 /pmc/articles/PMC6689286/ /pubmed/31401713 http://dx.doi.org/10.1007/s11892-019-1194-6 Text en © The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Pathogenesis of Type 1 Diabetes (A Pugliese and SJ Richardson, Section Editors)
Moin, Abu Saleh Md
Butler, Alexandra E.
Alterations in Beta Cell Identity in Type 1 and Type 2 Diabetes
title Alterations in Beta Cell Identity in Type 1 and Type 2 Diabetes
title_full Alterations in Beta Cell Identity in Type 1 and Type 2 Diabetes
title_fullStr Alterations in Beta Cell Identity in Type 1 and Type 2 Diabetes
title_full_unstemmed Alterations in Beta Cell Identity in Type 1 and Type 2 Diabetes
title_short Alterations in Beta Cell Identity in Type 1 and Type 2 Diabetes
title_sort alterations in beta cell identity in type 1 and type 2 diabetes
topic Pathogenesis of Type 1 Diabetes (A Pugliese and SJ Richardson, Section Editors)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689286/
https://www.ncbi.nlm.nih.gov/pubmed/31401713
http://dx.doi.org/10.1007/s11892-019-1194-6
work_keys_str_mv AT moinabusalehmd alterationsinbetacellidentityintype1andtype2diabetes
AT butleralexandrae alterationsinbetacellidentityintype1andtype2diabetes